Previous close | 94.70 |
Open | 93.71 |
Bid | 37.70 x 1000 |
Ask | 150.78 x 800 |
Day's range | 92.74 - 95.13 |
52-week range | 78.08 - 124.11 |
Volume | |
Avg. volume | 68,104 |
Market cap | 1.423B |
Beta (5Y monthly) | 1.41 |
PE ratio (TTM) | 81.44 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.76 (1.86%) |
Ex-dividend date | 22 May 2024 |
1y target est | N/A |
With earnings estimate revisions on the rise for these top medical stocks, they certainly shouldn't be overlooked given their blazing historical performances.
On May 30, 2024, Christopher Reading, Chairman of the Board and Chief Executive Officer of US Physical Therapy Inc (NYSE:USPH), sold 2,900 shares of the company.
On May 15, 2024, Edward Kuntz, Director of US Physical Therapy Inc (NYSE:USPH), executed a sale of 2,500 shares of the company.